Can Contrast-Enhanced Spectral Mammography Improve the Accuracy of a Diagnosis

Breast Screening Clinical Trial

Official title:
Contrast-Enhanced Spectral Mammography: Potential to Improve Diagnostic Accuracy

Status Terminated

Clinical Trial Summary

The purpose of this study is to test whether contrast-enhanced spectral mammography (CESM) may be able to reduce the number of unnecessary biopsies in women whose screening mammograms had abnormal findings.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Breast Screening

Clinical Trial Details

NCT number	NCT03929822
Study type	Observational
Source	Memorial Sloan Kettering Cancer Center
Contact
Status	Terminated
Phase
Start date	April 23, 2019
Completion date	January 19, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03233191` - Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast Cancer	Phase 3
Completed	`NCT01977599` - Are Text Message Reminders an Effective Intervention for Improving the Uptake of Breast Screening?	N/A
Completed	`NCT02174406` - Clinical Utility of Whole Breast Screening Ultrasound in Patients Undergoing Digital Breast Tomosynthesis
Active, not recruiting	`NCT03672331` - My Personalized Breast Screening	N/A
Active, not recruiting	`NCT04761055` - Study of iBreast, a Handheld Device to Detect Breast Abnormalities During Screening Visits for Breast Cancer	N/A
Completed	`NCT03846947` - Novel MRI Sequence MR Fingerprinting in Breast MRI Feasibility Study	N/A